This company seems to have been delisted
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) - Total assets
Total assets on the balance sheet as of March 2023 : $0.10 Billion USD
According to Spectrum Pharmaceuticals 's latest financial reports the company's total assets are $0.10 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Spectrum Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.10 B | -7.36% |
| 2021-12-31 | $0.11 B | -43.32% |
| 2020-12-31 | $0.19 B | -25.29% |
| 2019-12-31 | $0.26 B | -32.61% |
| 2018-12-31 | $0.39 B | -19.81% |
| 2017-12-31 | $0.48 B | 13.68% |
| 2016-12-31 | $0.42 B | 1.79% |
| 2015-12-31 | $0.42 B | -14.04% |
| 2014-12-31 | $0.49 B | -1.83% |
| 2013-12-31 | $0.49 B | -1.41% |
| 2012-12-31 | $0.50 B | 80.31% |
| 2011-12-31 | $0.28 B | 71.59% |
| 2010-12-31 | $0.16 B | -5.49% |
| 2009-12-31 | $0.17 B | 38.8% |
| 2008-12-31 | $0.12 B | 116.78% |
| 2007-12-31 | $57.54 M | 8.33% |
| 2006-12-31 | $53.11 M | -18.38% |
| 2005-12-31 | $65.07 M | 59.66% |
| 2004-12-31 | $40.75 M | 48.81% |
| 2003-12-31 | $27.38 M | 693.17% |
| 2002-12-31 | $3.45 M | -73.07% |
| 2001-12-31 | $12.82 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Teva Pharmaceutical Industries TEVA | $38.41 B | 35,576.81% | 🇮🇱 Israel |
 Seagen
SGEN | $3.63 B | 3,275.21% | 🇺🇸 USA |
 Curis CRIS | $39.32 M | -63.48% | 🇺🇸 USA |
 Biogen BIIB | $28.03 B | 25,934.92% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $92.42 B | 85,738.87% | 🇺🇸 USA |
 Abbott Laboratories ABT | $81.44 B | 75,542.44% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | 92,717.27% | 🇨🇭 Switzerland |
 Johnson & Johnson JNJ | $193.67 B | 179,766.26% | 🇺🇸 USA |
 Pfizer PFE | $208.02 B | 193,099.91% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $78.54 B | 72,843.49% | 🇬🇧 UK |